How To Accept Payments For A Clinical Research

A clinical research business bills sponsors on milestones, pays participants stipends, and reconciles both against protocols that auditors will read later. Getting paid well means invoicing exactly what the contract permits, exactly when it permits it, with documentation that survives review. Here is the setup.

Figures current to July 28, 2026 and rechecked each quarter.

How clinical research money actually arrives

Four flows. Sponsor milestone payments: startup fees, per-patient amounts as visits complete, and close-out payments, all governed by the clinical trial agreement. Pass-through and reimbursable costs: laboratory, imaging, shipping, and site fees billed at cost per the budget. Participant stipends and reimbursements flowing outward to volunteers. And investigator or consulting fees where applicable. Almost nothing here is discretionary, since the agreement and budget define what may be billed and when.

By the numbers (July 28, 2026)

The governing 2026 rate here is 3.3% + 30¢ online or on a card-paid invoice. Processing a $12,500 per-patient milestone invoice costs $413, against $10.00 on ACH, where the 1% rate caps at $10, saving $403. Sponsor payments at this scale arrive by transfer as standard, which makes card acceptance relevant mainly for smaller ancillary and investigator-initiated work.

Invoice against the budget, not against effort

The most common revenue leak in site-level research is work performed that the budget does not cover, screen failures, extra visits, unanticipated procedures, absorbed because raising it feels administrative. The fix is at negotiation: ensure the budget includes screen failure compensation, per-procedure line items, and a mechanism for protocol amendments, then bill every eligible item as it occurs rather than at the end. Sites that invoice promptly and accurately against a well-negotiated budget operate profitably; sites that do neither subsidise sponsors.

The payment lag, which is structural

Sponsor payments commonly arrive well after the visits that earned them, sometimes quarterly, while the site pays staff, laboratories, and participants throughout. Startup fees exist partly to fund that gap and should be negotiated rather than accepted as offered. Track outstanding milestones as receivables against the agreement, reconcile payments to specific visits rather than accepting lump sums without detail, and query discrepancies immediately, because unreconciled sponsor payments are extremely difficult to untangle a year later.

Participant stipends, which flow the other way

Payments to participants are an outbound obligation with their own requirements: amounts specified in the protocol and approved by the reviewing ethics committee or board, paid on the stated schedule, and documented to audit standard. Methods vary, reloadable cards, transfers, and vouchers are all used, and the choice affects participant experience and record keeping. Applicable tax reporting requirements may attach to participant payments above certain thresholds in some jurisdictions, which is worth confirming before enrolment rather than at year end.

Documentation, audit, and the rails

Every invoice should trace to the agreement, the budget line, and the source documentation for the visit or procedure it bills, because financial records in research are reviewed alongside clinical ones. Keep the trail complete and reconcilable. On rails, sponsor payments at five and six figures arrive by transfer as a matter of course, and card acceptance is relevant mainly for smaller ancillary services or investigator-initiated work billed directly. The compliance framework, governed by the protocol, the agreement, and applicable regulation, comes before any payment convenience.

Sources

• NerdWallet — Square Fees: Calculator and Pricing for 2026
• Swipesum — Square Fees Explained 2026 (verified against Square's published pricing)

What people ask me

How do research sites get paid?

On sponsor milestones defined by the clinical trial agreement: startup fees, per-patient amounts as visits complete, pass-through costs, and close-out payments.

Where do sites lose money?

On work the budget does not cover, especially screen failures and unanticipated procedures. Negotiate those line items into the budget, then bill each item as it occurs.

How should the payment lag be managed?

With negotiated startup fees, milestones tracked as receivables against the agreement, and payments reconciled to specific visits rather than accepted as unexplained lump sums.

What governs participant stipends?

Amounts specified in the protocol and approved by the reviewing board, paid on schedule and documented to audit standard, with tax reporting thresholds worth confirming in advance.

What standard should financial records meet?

Every invoice should trace to the agreement, the budget line, and the source documentation, since financial records in research are reviewed alongside clinical ones.

Heads up: some links here are affiliate links. If you buy through one, I may earn a small commission. It costs you nothing extra. I only recommend tools I use myself.